Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

transient leukemia

(TRAN-zee-ent loo-KEE-mee-uh)
A bone marrow disorder that can occur in newborns who have Down syndrome. It is marked by abnormal, immature blood-forming cells in the blood and bone marrow (especially the cells involved in making platelets). The liver may also be larger than normal. Transient leukemia is caused by mutations (changes) in a gene called GATA1. Transient leukemia usually goes away on its own within the first 3 months of life. Sometimes transient leukemia causes severe or life-threatening problems, such as bleeding problems, infection, heart, kidney, and liver failure, and abnormal build-up of fluid in the tissues that cover the organs in the body. Infants who have transient leukemia have an increased risk of developing acute myeloid leukemia (AML) before the age of 3 years. Also called TAM, TMD, transient abnormal myelopoiesis, and transient myeloproliferative disorder.
Search NCI's Dictionary of Cancer Terms